10 Best Get Rich Quick Stocks to Buy Right Now
At a time when many investors are seeking life-changing opportunities, stocks capable of generating outsized returns continue to attract significant interest.
Neumora Therapeutics Inc. (NMRA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Siren L.L.C. Raymond Debbane | 8,497,822 | $14,446,297 | 0.29% | |
| 2. | SOFTBANK GROUP CORP Masayoshi Son | 6,090,301 | $10,353,512 | 0.06% | |
| 3. | MIC Capital Partners Mubadala Investment | 4,460,700 | $7,583,190 | 1.92% | |
| 4. | 3,835,200 | $6,519,840 | +591% | 0.01% | |
| 5. | OrbiMed Advisors Samuel Isaly | 2,139,882 | $3,637,799 | 0.07% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $2.61 | 1,915,700 | $4,999,977.00 | 6,046,907 | 2025-10-27 | Filing | |
| $11.98 | 3,357 | $40,216.86 | 4,131,207 | 2023-11-14 | Filing | |
| $11.75 | 31,653 | $371,922.75 | 4,127,850 | 2023-11-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.60 | 21,055 | $33,599.57 | 0 | 2026-08-21 | Filing | |
| $1.59 | 20,553 | $32,779.98 | 48,750 | 2026-08-21 | Filing | |
| $1.51 | 66,711 | $101,000.45 | 0 | 2026-08-20 | Filing | |
| $1.51 | 67,741 | $102,586.97 | 48,750 | 2026-08-20 | Filing | |
| $1.65 | 30,918 | $50,887.94 | 0 | 2026-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,791,869 | $13,246,178 | 0% | |
| 2. | 4,669,585 | $7,938,295 | 0% | |
| 3. | 3,498,869 | $5,948,077 | 0% | |
| 4. | 3,309,123 | $5,625,509 | 0.06% | |
| 5. | 2,607,289 | $4,433,341 | 0% |
News See All
10 Small Cap Stocks with Potential to Rise 1000 Percent
Small-cap stocks have returned to the market’s risk conversation in 2026.
10 Stocks Under $5 That Will Explode
On April 8, 2026, in an interview with Reuters, Matt Stucky, chief portfolio manager for equities at Northwestern Mutual Wealth Management Company, discussed his inclination toward small- and mid-cap ...
Neumora Therapeutics (NMRA) Positioned to Capitalize on Blockbuster Opportunity
On February 17, Myles Minter from William Blair upgraded his rating on Neumora Therapeutics Inc. (NASDAQ:NMRA) from Market Perform to Outperform.
11 Most Popular AI Penny Stocks to Buy Now
The need for the adoption of Artificial Intelligence (AI) is becoming increasingly pivotal for businesses to elevate their operations.
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511
Neumora Therapeutics Inc (NASDAQ:NMRA) is among the best NASDAQ penny stocks to buy according to analysts.
12 Best NASDAQ Penny Stocks to Buy According to Analysts
Big technology stocks are no longer leading the stock market higher, and a rotation away from large caps is gaining momentum instead.
10 Best New Penny Stocks to Invest In
On December 30, TipRanks reported that the Goldman Sachs portfolio strategy research team is optimistic about small-cap stocks heading into early 2026.
Needham Lifts PT on Neumora Therapeutics (NMRA) to $8 From $6, Keeps a Buy Rating
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the best stocks under $5 with highest upside potential. On October 28, Needham lifted its price target on Neumora Therapeutics, Inc.
14 Stocks Under $5 with Highest Upside Potential
On October 28, Paul Tudor Jones, Tudor Investment Corporation founder and CIO and Robin Hood Foundation founder and board member, appeared on CNBC’s 'Squawk Box' to talk about the latest trends in the...